Existing treatments for eczema, which affects about 17 percent of children in developed countries, are expensive or have side effects. A new study suggests a different approach to eczema, one that stimulates a natural brake on the allergic attack, made by T regulatory cells in the skin.
from Top Health News -- ScienceDaily http://ift.tt/2HaFvdW
